CIK 0001001316 · Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363898269
- Phone
- (212) 554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K/A Event Material agreement · Agreement ended
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Agreement ended
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- SC 13D/A Stake Beneficial Ownership Report
Page 32 of 58 · 1,151 filings